Background: A stigma is a pejorative social label. Stigmatisation is a process by which individuals are made to experience isolation and reduced opportunities in life. Some diseases are particularly associated with stigmatising attitudes; this applies particularly to sexually transmitted infections. Although several studies report the eVects of stigma, no study to date has attempted to investigate its nature, which is a prerequisite to designing health interventions. Methods: This qualitative, exploratory study investigated the experience of stigma among young women recently diagnosed with an STI and considered the implications of these experiences in terms of maximising access to GUM clinics. Results: Three themes were identified from interviews undertaken with women recruited in family planning and genitourinary medicine (GUM) clinics: the perception of STIs as a condition of "others," the threatening nature of the GUM clinic, and the evolution of the experience of stigma within the GUM clinic.
Introduction
Both the causes and eVects of stigma are important medical issues. A stigma is a pejorative social label, attached to those who are perceived to deviate from some socially constructed expectation, whether this is physical, mental, or behavioural. Stigmatisation is a process by which individuals are made to experience isolation and reduced opportunities in life. 1 Some diseases, because of their link with behaviours that are regarded as "deviant" or amoral, are particularly associated with stigmatising attitudes. 2 Sexually transmitted infections (STIs) have long been associated with the institutionalised persecution and ostracism of aVected individuals, because of their direct association with sexual behaviour, with its attendant religious, cultural, and political dimensions. 3 STIs have been blamed for a wide range of societal ills, ranging from the disintegration of family life to the breakdown of social order and the fall of empires. 4 Historically, many public health control eVorts have, paradoxically, merely served to intensify stigma, by reinforcing fears and marginalising aVected individuals. 5 Stigma has previously been reported in association with a diagnosis of STI, 6 7 is associated with delay in seeking treatment, 8 9 and is perceived by prospective patients as a barrier to referral to genitourinary medicine (GUM) clinics. 10 Although previous work in this area has described the possible eVects of stigma, few studies have investigated its nature. Such research is important for two reasons. Firstly, empirical evidence is required to investigate the significance of stigma for both patients and service providers. Secondly, understanding stigma in relation to GUM service use is a prerequisite to design of interventions in this area. This exploratory study aimed to investigate the experience of stigma among young women recently diagnosed with an STI and to consider the implications of these experiences for optimising access to GUM clinics.
Methods
This study is part of a larger investigation in Glasgow into the psychosocial impact of genital Chlamydia trachomatis infection in women. 7 Women with a recent chlamydia diagnosis were recruited from two large clinics in central Glasgow in 1997-8-one GUM clinic and one family planning clinic. A qualitative methodology was employed; this approach is well suited to the exploration of issues which are likely to be complex and/or poorly understood. 11 Semistructured interviews were open ended and non-directive. All interviews were conducted by BD. Interviews of between 40 minutes and 2 hours were audio recorded and transcribed verbatim. Transcripts were coded to identify emergent themes; those concerning stigma were then further analysed, separately, by two investigators (BD and AS), to identify recurrent themes.
Results
Seventeen women (age range 18-29) agreed to participate, 10 from the GUM clinic and seven from the family planning clinic (participation rate 62%). None of the respondents attending the family planning clinic had ever attended a GUM department and, of those women recruited from the GUM clinic, only one had previously attended. Six participants had coinfection with other STIs (four with genital warts, one with gonorrhoea, and one with both pelvic inflammatory disease (PID) and genital warts). Three themes were identified from the data: the perception of STIs as a condition of "others," the threatening nature of the GUM clinic, and the evolution of the experience of stigma within the GUM clinic.
STIS-A PROBLEM OF "OTHERS" The majority of women in the sample had never previously considered themselves to be at any risk of STIs: Women perceived a low level of community awareness about STIs and risk factors for their acquisition; this increased feelings of isolation, by escalating anxieties about disclosure to others. They were also pessimistic about the ability of others to understand fully the issue of vulnerability to STI: Thus, simply being identified as a patient attending a GUM clinic was perceived as rendering women vulnerable to sanction. The clinic itself clearly shared the stigmatising connotations associated with the conditions it treated and, by implication, the "deviant" population it served. In contrast, other sexual health services had a "safer" association. 
They don't want to know about them [STIs], they don't want to think that you could ever get them because everyone as I said probably thinks like me and thinks that isn't something that I will ever have to worry about. It's like 'I don't sleep around-I won't get it.' So they automatically don't think they need

Discussion
Stigma associated with GUM clinics is recognised to be a barrier to patient access. This has led to exploration of alternative public health strategies for the diagnosis and management of STIs, despite the absence of research investigating the nature and eVects of stigmatisation in the context of GUM services. Most importantly, the question of how modern GUM services can work therapeutically to modify individuals' experiences of stigma associated with STIs has been largely ignored.
This study has investigated the experience of stigma reported by young women attending a GUM clinic in a metropolitan city and the part that stigma plays in accessing GUM services. Its main findings are that the stigma surrounding STIs pervades GUM clinics, that this can create a barrier to access and may induce fear and isolation in individuals who do manage to attend such clinics. However, while attending the GUM clinic was experienced as stressful, it did not correspond to study participants' worst fears, and reduced anxiety was associated with staV eVorts to "normalise" the experience of having an STI.
Negative feelings about STIs, such as guilt, "dirtiness," and fear of the moral judgments of others have previously been reported in individuals who suspect they are at risk of STI. 6 7 10 These feelings are then transferred to the services for treating STIs-GUM clinics. Such negative views are not limited to patients; previous work in Glasgow demonstrated that 86% (n = 101) of healthcare workers surveyed perceived GUM services as stigmatising to patients and this was regarded as a significant barrier to referral.
In this study, the factors contributing to stigma in relation to GUM clinics were those connected to STIs themselves, specifically their association with deviancy and social undesirability. Like the "alien" nature of STIs themselves, they believed that GUM clinics catered for "other" groups of people and attendance at such clinics associated the attendee with such groups in the minds of staV and the wider community.
The impact of stigma associated with GUM clinics was, firstly, to reduce the perceived accessibility of services by patients, because they did not consider themselves to be within the social category perceived as "typical" GUM clinic attendees. GUM clinics were viewed as more "dangerous" than family planning services, which had a more benign appeal. Secondly, stigma adversely aVected the experiences of individuals who did manage to access GUM clinics. Fears of judgmental staV, censure, and disclosure, as well as a generalised anxiety related to inexperience of clinic procedures, were reinforced by the aura surrounding STIs and GUM clinics.
The women in this study experienced "felt," rather than "enacted," stigma. The first refers to a person's internal negative thoughts about the impact of a condition, the second to the words or actions of other people against an aVected person. 13 In some respects, it resembles the hidden distress model of coping with epilepsy, 14 where adults experience a high degree of "felt" stigma and adopt strategies of concealment which reduce the possibility of enacted stigma. Thus, felt stigma is potentially more disruptive to suVerers than is enacted stigma. 15 In the case of STI, felt stigma may mitigate against individuals disseminating their relatively positive experiences of attending a GUM clinic to their wider peer group and thus may contribute significantly to continuing fear of GUM clinics.
What implications does this study have for sexual healthcare providers and planners? One of the most important consequences of stigma is reduced access to GUM services. Previous research has demonstrated that lack of knowledge about GUM clinics and inexperience with clinic procedures increases delay in attendance. 8 9 The respondents in this study had very little previous knowledge or understanding of STIs. Public awareness of STIs and GUM services must be improved, both in quantity and quality. Secondly, the evidence in this study that family planning services are perceived as more acceptable, because of their distance from a "disease model" of health care supports the case for integrated models of sexual health care. Co-location of GUM with other reproductive healthcare services provides opportunities to circumvent the stigma associated with "stand alone" GUM services and optimise access to the destigmatising experience which GUM clearly provides. Thirdly, medical, nursing, and counselling staV in GUM clinics (for those who do manage to access them) can play a major part in reducing stigma and they should be supported, through training and staV development, in this role. Finally, previous public health strategies merely intensified the marginalisation and stigma associated with STIs and GUM clinics; deliberate concealment of GUM clinics in inaccessible locations, giving them euphemistic titles, or naming them after great dermatovenereologists has often served to disguise their true identity and purpose. These physical and linguistic eVorts to render open access diYcult have reinforced public silence and ignorance of the nature of STIs, paradoxically contributing to their further stigmatisation. Strenuous eVorts should be made to overcome the stigma associated with STIs and, by default, GUM services, and to present sexual health services in a way that is seen as inclusive and relevant to a wide range of individuals.
However, the diYculty of this task should not be underestimated. Given the social and moral taboos and complex emotional investments associated with sexual activity 16 it is perhaps unsurprising that a pervasive sense of stigma is still, in the 21st century, associated with infections transmitted via sexual activity and the services which treat them. Future national strategies designed to improve access to sexual health services should formally investigate the role of stigma, both in relation to issues of access and the impact of utilising such services on the experience of stigma. 
